Poster Dimensions
Poster boards are 2m tall by 1,5m wide. Make sure your Poster fits (it can be smaller, but not larger than the board dimensions).
 
Poster Mounting
To preserve the boards (made of transparent plastic), please use adhesives that leave no residue (e.g. transparent tape from Wurth, or similar).

Mount your poster between 8:00 and 8:50
(July 13, 2018) and keep it on for both sessions.



click the image to zoom in on Poster boards

Poster Session A                    Bioenergetics, Cancer, and Metabolism               

Bioenergetics


[p01] Impact of starvation on mitochondrial hydrogen sulfide oxidation in mouse liver Inês Mateus


[P02] Mitochondriotropic cinnamic acid antioxidants increase cellular stress responses in HepG2 cells: involvement of (mt)ROS signaling? Ricardo Amorim


[P03] Mitochondrial function and oxidative stress in epicardial versus subcutaneous adipose tissue from heart failure patients with and without diabetes Ana Catarina R. G. Fonseca


[P04] Morphology independent regulation of mitochondrial bioenergetics by Mfn2 relies on endoplasmic reticulum-mitochondria Ca2+ transfer Sergi Casellas-Díaz


CANCER


[P05] The therapeutic effect of exercise training in cancer-related cardiac remodeling in a pre-clinical model of urothelial carcinoma Rita Nogueira-Ferreira


[P06] Exercise training protect against mitochondrial dysfunction in cancer-related muscle wasting Ana Isabel Padrão


[P07] Mitoxantrone prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant doses Vera Marisa Freitas Costa


METABOLISM


[P08] mtDNA from Healthy and Osteoarthritic (OA) patients have different mitochondrial activity, data obtained using transmitochondrial cybrid model Mercedes Fernandez-Moreno


[p09] Main metabolites of 5-fluorouracil + adriamycin + cyclophosphamide (FAC) are not major contributors to FAC toxicity in H9c2 cardiac differentiated cells Ana Reis-Mendes


[p10] Liver mitochondrial alterations associated to an early stage of Non-Alcoholic Fatty Liver Disease Inês C.M. Simões


[p11] Effect of olanzapine on mitochondria function after three and six weeks of treatment in rats Giada Di Nunzio


[p12] Human urine-derived cells from young and old donors for assessing glycolytic and oxidative phosphorylation functions Guida Bento


[p13] Virtual Mitochondrion: A Modular and Multi Level Whole-Mitochondrion Model Jean-Pierre Mazat


[p14] Mitochondriotropic cinnamic acid antioxidants improves steatosis in a Non-Alcoholic Fatty Liver Disease (NAFLD) cell model José Teixeira


[p15] Sustained Prevalence of a Glycolytic Metabolic Profile in CD8+ T Cells from Rheumatoid Arthritis Patients under Low Glucose Availability Francisco X. Carvalho


[p16] Metabolic remodeling during RANKL-induced osteoclast differentiation Adriana Marques Carvalho


[p17] Standardization and characterization of cell culture conditions for OXPHOS induction and for mitochondrial health studies in human fibroblasts Cláudio F. Costa


[p18] Effect of multi-functional mitochondria-targeted antioxidants in human skin fibroblasts Rodrigo Carreira


[p19] Remodeling of liver mitochondrial bioenergetics in offspring from obese mothers in a sheep model Inês Cardoso


[p20] Being obese during pregnancy: the mitochondrial impact on maternal hepatic tissue Susana P. Pereira


[p21] Determination of the antioxidant enzymatic activity of catalase in animal samples by a novel high-throughput assay Luís Grilo


[p22] The antibiotic doxycycline impairs cardiac mitochondrial and contractile function Rob Wust


OTHER


[p23] Role of Mitochondria-Associated Membranes in the endoplasmic reticulum stress response in the innate immune system Ana Catarina de Jesus Pais Pereira


[p24] The role of mitochondria in Drosophila wound healing Susana Ponte


[p25] Skin aging and mitochondriotropic antioxidants based on dietary hydroxycinnamic acids Caroline Veloso



Poster Session B                    Mitochondrial Genetics and Neuroscience

GENETICS


[P26] Next-generation sequencing evaluation of mitochondrial biomarkers in heart failure with preserved ejection fraction (HFpEF) Nicole Pedro


[P27] Mitochondrial DNA mutation in stroke patients-a highway to a Precise Medicine Filipa S. Carvalho

    

[P28] Multiple sclerosis and mitochondria: a longitudinal cell-specific approach to mitochondrial DNA mutations Filipe Cortes Figueiredo


[P29] Using real-time PCR for relative quantification of mitochondrial DNA in Neurospora crassa João Monteiro


NEUROSCIENCE


(Alzheimer's Disease)


[P30] Exploring the neuroprotective effects of the mitochondrial uncoupler 2,4-Dinitrophenol in an in vitro model of Alzheimer´s disease Susana Cardoso


[P31] Mitochondrial ROS activate WWOX1 pathway under hyperglycemic conditions leading to neuronal death Cristina Carvalho


[P32] The bittersweet side of O-GlcNAcylation in Alzheimer's disease-related mitochondrial abnormalities Tiffany Santos Pinho


[P33] Amyloid-β peptide compromises neural stem cell fate by irreversibly disturbing oxidative state and blocking mitochondrial biogenesis and dynamics Maria Filipe Ribeiro


[P34] Oligomeric amyloid-beta peptide-induced redox dendritic mitochondrial changes in mature hippocampal neurons: role of NMDA receptors and Src kinase Sandra Mota


(Huntington's Disease)


[P35] Targeting mitochondria in Huntington’s disease: effects of MitoQ in the R6/2 mouse model Liliana M. Almeida


[P36] Differential mHtt proteostasis and mitochondrial function as predictors of striatal vulnerability in Huntington's Disease Tânia R. Soares


[P37] Modulation of Hsp70 and the proteostasis of N-terminal and full-length huntingtin in cellular models of Huntington’s disease Sara D. Reis


(Parkinson's Disease)


[P38] The role of PINK1 in Mitochondrial Quality Control Elvira P. Leites


[P39] Biological Implications of Differential Expression of Mitochondrial-Shaping Proteins in Parkinson’s Disease Ana Freitas


[P40] Unravelling the impact of Parkinson's Disease PINK1 clinical mutations on mitophagy Filipa Gonçalves


[P41] Mitochondrial angiotensin II receptors in dopaminergic neurons. Role in aging-related vulnerability to neurodegeneration Rita Valenzuela


[P42] Elderberry anthocyanins-enriched extract to modulate mitochondrial dysfunctions underlying Parkinson’s disease Dina Neves


[P43] Targeting mitochondria with mitochondria-targeted cinnamic antioxidants: a new avenue for sporadic Parkinson’s Disease therapy Cláudia M. Deus


[P44] A bacterial neurotoxin negatively impacts mitochondrial metabolism: microbial twist for PD etiology Ana Raquel Esteves


[P45] Mitochondrial superoxide generation induces Parkinson’s disease phenotypes in zebrafish and huntingtin aggregation in human cells Brígida R. Pinho


(Neuroscience - Other)


[P46] Dose-dependent analysis of mitochondrial parameters in differentiated SH-SY5Y cells exposed to mitochondrial toxicants Rui F. Simões


[P47] Presence and function of mitochondrial angiotensin 1-7/mas receptor axis in the substantia nigra María Alicia Costa-Besada


[P48] Synaptic mitochondria: In search of the functional consequences of its proteomic fingerprint Andreia Faria-Pereira


[P49] Unravelling mitochondrial dynamics and turnover in the synapse Carlos Eduardo Cardanho dos Ramos


[P50] Mfn2 deficiency upregulates apoptosis-related genes in mouse primary cortical neurons Marc Segarra-Mondejar